Does PAZOPANIB Cause Neoplasm malignant? 195 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 195 reports of Neoplasm malignant have been filed in association with PAZOPANIB (Pazopanib). This represents 0.9% of all adverse event reports for PAZOPANIB.
195
Reports of Neoplasm malignant with PAZOPANIB
0.9%
of all PAZOPANIB reports
77
Deaths
27
Hospitalizations
How Dangerous Is Neoplasm malignant From PAZOPANIB?
Of the 195 reports, 77 (39.5%) resulted in death, 27 (13.8%) required hospitalization, and 4 (2.1%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PAZOPANIB. However, 195 reports have been filed with the FAERS database.
What Other Side Effects Does PAZOPANIB Cause?
Death (3,767)
Diarrhoea (2,907)
Fatigue (1,883)
Nausea (1,879)
Malignant neoplasm progression (1,471)
Drug ineffective (1,135)
Decreased appetite (1,116)
Vomiting (1,072)
Hypertension (1,004)
Malaise (764)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which PAZOPANIB Alternatives Have Lower Neoplasm malignant Risk?
PAZOPANIB vs PEANUT
PAZOPANIB vs PEG INTERFERON
PAZOPANIB vs PEG-INTERFERON ALFA 2A
PAZOPANIB vs PEGASPARGASE
PAZOPANIB vs PEGASYS